NASDAQ$PGNY

Progyny Inc · Q1 2026 earnings

Q1 2026 earnings · · Investor relations

Briefing

Progyny reported Q1 2026 revenue of $328.5M with net income of $24.2M and diluted EPS of $0.29.

For the quarter ended March 31, 2026, Progyny revenue was $328.5 million versus $324.0 million a year ago. Net income was $24.2 million, or $0.29 per diluted share, compared with $15.1 million and $0.17 per share in Q1 2025. Income from operations was $35.4 million.

  • Revenue $328.5M (+1% YoY); operating income $35.4M.
  • Net income $24.2M; diluted EPS $0.29 vs $0.17 prior year.
  • Fertility benefits utilization remained core driver.

Headline financials

Total Revenue

$329M

Previous: $324M+1.4%
EPS (adj)

$0.29

Previous: $0.18+61.1%
Capital Expenditures

-$6.35M

Previous: -$2.84M-123.3%
Net Income

$24.2M

Previous: $15.1M+60.9%
Operating Income

$35.4M

Previous: $24.2M+46.4%
Gross Profit

$83.1M

Previous: $75.8M+9.6%

Revenue & EPS history

Progyny · Revenue · Quarterly

$329M

Q1 2026+1.4%vs Q1 2025
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Revenue by segment

Progyny · $281M total across 2 segments · Q3 2023

  • Fertility Benefit Services
    $175M+35.4%
  • Pharmacy Benefit Services
    $106M+39.0%

Forward guidance

Employer fertility benefits; annual guidance typically provided on earnings calls.

Tailwinds

  • Earnings growth on stable employer client base.

Headwinds

  • Revenue growth modest; dependent on member utilization trends.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

-1.1%

Avg return

Earnings day

-0.3%

Avg return

5 days after

-0.2%

Avg return

30 days after

38%

11 / 29 earnings

Positive

+26.4%

Q2 2022

Best reaction

-20.5%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.5%+25.4%+38.2%
Q4 2025-20.5%-20.0%-22.4%
Q3 2025+24.3%+33.6%+33.4%
Q1 2025-9.7%-6.5%-7.2%
Q4 2024-1.5%-5.2%-4.3%
Q3 2024-18.5%-19.3%-12.9%
Q2 2024-17.7%-14.7%-6.4%
Q1 2024-14.4%-14.6%-14.2%
Q4 2023-13.1%-9.7%-4.3%
Q3 2023-4.3%-2.1%+17.8%
Q2 2023+4.9%-2.8%-8.6%
Q1 2023+9.3%+5.9%+16.8%
Q4 2022+22.9%+18.4%+7.7%
Q3 2022-2.6%+2.0%-13.8%
Q2 2022+26.4%+25.5%+15.4%
Q1 2022-7.1%-15.6%-23.1%
Q4 2021+11.5%+13.0%+31.6%
Q3 2021+2.5%+5.8%-22.2%
Q2 2021-12.8%-17.1%+4.3%
Q1 2021-3.2%-8.7%+18.4%
Q4 2020-15.5%-14.9%-14.4%
Q3 2020-0.3%+7.0%+38.7%
Q2 2020+0.4%+8.4%-0.9%
Q1 2019-2.4%+4.8%-13.7%
Q1 2020+21.8%+18.8%+2.1%
Q4 2017-3.7%-6.3%-8.3%
Q4 2019-12.2%-15.5%-39.0%
Q4 2018-0.2%-5.0%-7.0%
Q3 2019+0.5%+0.3%-6.5%
Q2 2019
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro